Poor bone health with related morbidity is a major problem with Duchene Muscular Dystrophy (DMD). Decreased mobility and long-term corticosteroid therapy are involved in poor bone health in DMD. We investigated bone mineral density and bone metabolism in 30 steroid treated DMD patients and also compared mentioned factors between ambulated and non-ambulated patients.
Read the full research article and you will find why I’m so excited
Ann: ATL1102 Data presented at MDA Annual Conference, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 1.0¢ | $71.80K | 7.180M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4649246 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 2600000 | 2 |
View Market Depth
| Last trade - 15.21pm 13/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |